STAT stories you may have missed

In the race for a Covid-19 vaccine, Pfizer turns to a scientist with a history of defying skeptics — and getting results.

Opinion: FDA’s plasma EUA means we may never have good answers on the efficacy of the treatment. 

The first documented Covid-19 reinfection was confirmed in Hong Kong. 

Inside the new fight brewing over the 340B drug discount program. 

A drug maker is paying out over $300,000 to settle gender descrimination lawsuits. 

Adam’s take: Do last week’s shocking FDA rejections signify a change at the agency? Don’t count on it.